COMBINATION OF SORAFENIB AND TRANSARTERIAL CHEMOEMBOLISATION (TACE) IN ADVANCED STAGE HEPATOCELLULAR CARCINOMA (HCC): A RETROSPECTIVE COHORT STUDY AT THREE GERMAN LIVER CENTERS

被引：0
|
作者：
Trojan, J. [1 ]
Goeller, M. [1 ]
Schott, E. [2 ]
Welker, M. W. [1 ]
Fischer, K. [3 ]
Schmidt, L. [3 ]
Paprottka, P. [3 ]
Zangos, S. [1 ]
Vogl, T. [1 ]
Bechstein, W. O. [1 ]
Zeuzem, S. [1 ]
Kolligs, F. T. [3 ]
机构：
[1] Klinikum Johann Wolfgang Goethe Univ, Frankfurt, Germany
[2] Campus Virchow Klinikum, Charite, Berlin, Germany
[3] Klinikum Univ Munchen, Munich, Germany
来源：
JOURNAL OF HEPATOLOGY | 2013年 / 58卷
关键词：
D O I：
10.1016/S0168-8278(13)60275-5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
273
引用
收藏
页码：S116 / S116
页数：1
相关论文
共 50 条
  • [1] Combination of Sorafenib and Transarterial Chemoembolization in Selected Patients with Advanced-Stage Hepatocellular Carcinoma: A Retrospective Cohort Study at Three German Liver Centers
    Koch, Christine
    Goeller, Markus
    Schott, Eckart
    Waidmann, Oliver
    op den Winkel, Mark
    Paprottka, Philipp
    Zangos, Stephan
    Vogl, Thomas
    Bechstein, Wolf Otto
    Zeuzem, Stefan
    Kolligs, Frank T.
    Trojan, Joerg
    CANCERS, 2021, 13 (09)
  • [2] The combination of sorafenib with transarterial chemoembolisation for hepatocellular carcinoma
    Cabrera, R.
    Pannu, D. S.
    Caridi, J.
    Firpi, R. J.
    Soldevila-Pico, C.
    Morelli, G.
    Clark, V.
    Suman, A.
    George, T. J., Jr.
    Nelson, D. R.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (02) : 205 - 213
  • [3] Sorafenib in combination with trans-arterial chemoembolization for advanced hepatocellular carcinoma: a retrospective Study at three German Liver centers
    Goeller, M.
    Fischer, K.
    den Winkel, P. Op
    den Winkel, M. Op
    Schott, E.
    Welker, M.
    Zangos, S.
    Vogl, T.
    Bechstein, W.
    Zeuzem, S.
    Kolligs, F.
    Trojan, J.
    INTERNIST, 2013, 54 : 35 - 35
  • [4] Hybrid Modelling of Transarterial Chemoembolisation Therapies (TACE) for Hepatocellular Carcinoma (HCC)
    H. Perfahl
    H. V. Jain
    T. Joshi
    M. Horger
    N. Malek
    M. Bitzer
    M. Reuss
    Scientific Reports, 10
  • [5] Hybrid Modelling of Transarterial Chemoembolisation Therapies (TACE) for Hepatocellular Carcinoma (HCC)
    Perfahl, H.
    Jain, H., V
    Joshi, T.
    Horger, M.
    Malek, N.
    Bitzer, M.
    Reuss, M.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [6] Conventional transarterial chemoembolisation in combination with sorafenib for patients with hepatocellular carcinoma: a pilot study
    Wolfgang Sieghart
    Matthias Pinter
    Michael Reisegger
    Christian Müller
    Ahmed Ba-Ssalamah
    Johannes Lammer
    Markus Peck-Radosavljevic
    European Radiology, 2012, 22 : 1214 - 1223
  • [7] Conventional transarterial chemoembolisation in combination with sorafenib for patients with hepatocellular carcinoma: a pilot study
    Sieghart, Wolfgang
    Pinter, Matthias
    Reisegger, Michael
    Mueller, Christian
    Ba-Ssalamah, Ahmed
    Lammer, Johannes
    Peck-Radosavljevic, Markus
    EUROPEAN RADIOLOGY, 2012, 22 (06) : 1214 - 1223
  • [8] Sequential therapy of transarterial chemoembolisation and sorafenib in intermediate stage hepatocellular carcinoma
    Welker M.W.
    Zangos S.
    Kriener S.
    Mönch C.
    Zeuzem S.
    Trojan J.
    Journal of Gastrointestinal Cancer, 2010, 41 (2) : 149 - 152
  • [9] Efficacy of radiofrequency ablation following transarterial chemoembolisation combined with sorafenib for intermediate stage recurrent hepatocellular carcinoma: a retrospective, multicentre, cohort study
    Wang, Xiao-Hui
    Liang, Wei
    Li, Hui
    Xie, Xiao-Yan
    Li, Shao-Qiang
    Chen, Min-Shan
    Liang, Ping
    Mao, Xian-Hai
    Zhou, Qun-Fang
    ECLINICALMEDICINE, 2023, 56
  • [10] Results of transarterial chemoembolisation (TACE) therapy for hepatocellular carcinoma (HCC) in a general hospital in Singapore
    Kwek, Boon Eu Andrew
    Teo, Eng Kiong
    Fock, Kwong Ming
    Yi-Lyn
    Tan, Jessica
    Chua, Tju Siang
    Poh, Choo Hean
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A51 - A51
12345